Thalidomide
Thalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo.
Product Specifications
CAS Number
50-35-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
258.23
Molecular Formula
C13H10N2O4
Notes
Research use only, not for human use.
Receptor
TNF-α
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog